- Harmony Biosciences Reports Strong First Quarter Financial Results and Acceleration of Its Growth Strategy; Advances Pitolisant Franchise to Extend Revenue Potential Beyond 2040; Strenghtens Sleep/Wake Leadership and Diversifies Into Rare Epilepsy
- Harmony Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates
- Harmony Biosciences Reports Strong Third Quarter 2023 Financial Results
- Harmony Biosciences Reports Second Quarter 2023 Financial Results and Business Updates
Key statistics
On Monday, Harmony Biosciences Holdings Inc (HRMY:NMQ) closed at 33.45, -14.81% below its 52-week high of 39.27, set on Sep 13, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 32.22 |
---|---|
High | 33.63 |
Low | 31.92 |
Bid | 31.75 |
Offer | 33.45 |
Previous close | 32.04 |
Average volume | 454.26k |
---|---|
Shares outstanding | 56.79m |
Free float | 33.31m |
P/E (TTM) | 14.28 |
Market cap | 1.88bn USD |
EPS (TTM) | 2.32 USD |
Data delayed at least 15 minutes, as of Jul 22 2024 21:00 BST.
More ▼